CONCLUSION: Despite LF15-0195 acting on B cells, the beneficial effects of this drug on nephrotic syndrome did not involve the induction of regulatory B cells. Moreover, the B cell depletion was not effective in reducing proteinuria, indicating that B cells are not a therapeutic target.
PMID: 24664644 [PubMed - as supplied by publisher] (Source: Journal of Nephrology)